title: Dalbavancin approved for acute skin infections.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000175:diagnosis; D017192:Skin Diseases, Bacterial / Q000175:diagnosis / Q000188:drug therapy*; D017334:Teicoplanin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents; D017334:Teicoplanin; C469289:dalbavancin